Dec 31, 2021

Arcturus Therapeutics Q4 2021 Earnings Report

Total Revenue
$5.79M
Previous year: $2.24M
+158.9%
EPS
-$1.47
Previous year: -$1.25
+17.6%
Gross Profit
$5.79M
Cash and Equivalents
$370M
Free Cash Flow
-$43.6M
Total Assets
$393M

Arcturus Therapeutics

Arcturus Therapeutics